Affordable Care Act

New and noteworthy

ACA Marketplace Plans Nationally Are Seeking a Median 18% Premium Increase for 2026

This analysis of insurers’ initial rate filings for Affordable Care Act Marketplace plans in all 50 states and DC finds the median proposed increase for 2026 is 18%, more than double last year’s proposed increase. The analysis also shows proposed rate changes by state and insurer.

Estimates of Additional Uninsured People Across the States

KFF Health Tracking Poll: ACA Enhanced Subsidies

From Drew Altman: Making the Marketplaces Great Again?

ACA Provisions in the 2025 Federal Budget Reconciliation Law

ACA Marketplaces

From Drew Altman: The Spotlight Is on Medicaid Cuts, But the ACA Marketplaces Could See a One-Third Cut in Enrollment

President and CEO Drew Altman shows how proposals contained in the House reconciliation bill could result in a one-third reduction in ACA Marketplace enrollment. “While all eyes are on the big Medicaid cuts being proposed in the House,” he writes, “significant changes are also being proposed that together would dramatically reduce enrollment in the ACA Marketplaces.”

ANALYSIS

Latest News

A Guide To Finding Insurance at 26‌
Why Young Americans Dread Turning 26: Health Insurance Chaos
Trump Voters Wanted Relief From Medical Bills. For Millions, the Bills Are About To Get Bigger.
KFF Health News' 'What the Health?': Here Come the ACA Premium Hikes

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Affordable Care Act

Filter

Past Week
Past Month
Past 6 Months
Past Year
Custom
Start Date

End Date

Clear Selections

Event (147)
Fact Sheet (173)
FAQs (423)
Feature (279)
From Drew Altman (189)
Interactive (40)
Issue Brief (556)
News Release (381)
Other Post (8)
Perspective (194)
Policy Watch (49)
Poll Finding (219)
Quick Take (21)
Report (106)
State Health Facts Indicator (37)
Tracker (8)
Video (11)

Clear Selections

Abortion (43)
ACA Marketplaces (526)
Access to Care (236)
Accountable Care Organizations (ACOs) (5)
Actuarial Value (7)
Administrative Costs (5)
Adolescents (11)
Affordability (194)
Alabama (3)
Alaska (5)
Arizona (4)
Arkansas (10)
Benefits (43)
Black or African American (5)
Build Back Better (6)
California (33)
Cancer (4)
Care Coordination (1)
Children (50)
Children's Health Insurance Program (CHIP) (51)
Chronic Diseases (16)
Colorado (11)
Congressional Budget Office (CBO) (7)
Connecticut (11)
Consumer Assistance (50)
Contraception (17)
Cost Sharing (129)
County-Level Data (11)
Courts (97)
Coverage (608)
Deficit Reduction (47)
Delaware (3)
Delivery System (38)
Demographics (19)
Diabetes (5)
Disability (67)
Disproportionate Share Hospital (DSH) (4)
District of Columbia (7)
Dual Eligible Individuals (39)
Ebola (2)
Economy (28)
Eligibility (86)
Employer-Sponsored Health Insurance (156)
Employment (11)
En Español (25)
End of Life (4)
Enrollment (204)
Family Planning (53)
Federal Budget (83)
Financing (127)
Florida (7)
Food Security and Nutrition (3)
Food Stamps (2)
Fraud, Waste and Abuse (2)
Gender Identity (9)
Georgia (5)
Greater Than HIV (1)
Gun Violence (3)
Hawaii (2)
Health Care Markets (2)
Health Care Utilization (9)
Health Centers (18)
Health I.T. (17)
Health Status (18)
Health System Performance (4)
Health Workforce (17)
Heart Disease (1)
High-Deductible Plans (9)
High-Risk Pools (9)
Hispanic or Latino (4)
HIV/AIDS in U.S. (45)
Home care/HCBS (26)
Hospitals (32)
Idaho (2)
Illinois (5)
Income and Assets (4)
Indiana (10)
Individual Mandate (54)
Individual Market (307)
International Comparisons (4)
International Cooperation (1)
Iowa (4)
Kansas (2)
Kentucky (15)
Long-Term Care (43)
Louisiana (7)
Low Income (119)
Maine (7)
Managed Care (38)
Maryland (11)
Massachusetts (13)
Maternal and Child Health (12)
Measles (2)
Medicaid Work Requirements (16)
Medical Loss Ratio (MLR) (17)
Medical Technology (4)
Medicare Advantage (27)
Medicare Part D (29)
Medicare's Future (31)
Medicare-for-all (60)
Medigap (1)
Michigan (12)
Minnesota (2)
Mississippi (3)
Missouri (7)
Montana (4)
Nebraska (2)
Nevada (10)
New Hampshire (4)
New Jersey (2)
New Mexico (5)
New York (8)
North Carolina (5)
North Dakota (2)
Nurses (1)
Nursing Facilities (6)
Obesity (4)
Ohio (12)
Oklahoma (3)
Opioids (11)
Oral Health (7)
Oregon (9)
Over-the-Counter Contraceptives (5)
Paid Leave (1)
Pennsylvania (6)
Physicians (26)
Politics (423)
Pre-existing Conditions (99)
Pregnancy (8)
Premium Support (10)
Premiums (159)
Prescription Drugs (116)
Prevention (48)
Prices (23)
Prior Authorization (2)
Public Health (32)
Puerto Rico/Virgin Islands (7)
Quality Measures (13)
Quality of Life (1)
race (1)
Race/Ethnicity (28)
Rate Review (10)
Reproductive Health (96)
Retiree Coverage (4)
Rhode Island (6)
Rural Health (4)
Safety Net (42)
Seniors (67)
Sexual Orientation (1)
Sexually Transmitted Diseases (STDs) (1)
Small Group Coverage (27)
Smoking (1)
Social Media (4)
South Carolina (5)
South Dakota (2)
State Budgets (97)
State-Level Data (91)
Stigma (1)
Subsidies (171)
Substance Use (1)
Taxes (46)
Telehealth (1)
Tennessee (9)
Texas (11)
Treatment (1)
U.S. Government Programs (1)
U.S. Military (4)
Utah (10)
Vaccines (4)
Vermont (6)
Virginia (11)
Voting (2)
Waivers (80)
Washington (18)
Wellness Programs (12)
West Virginia (5)
Wisconsin (6)
Wyoming (2)
Zika Virus (12)

Clear Selections

Beyond the Data (18)
Employer Health Benefit Survey (6)
Health Policy 101 (2)
Health System Tracker (21)
Health Tracking Poll (327)
Health Wonk Shop (2)
KFF Health News Announcements (1)
KFF/NPR Surveys (8)
KFF/Washington Post Surveys (8)
Medicaid Budget Survey (1)
Medicaid Eligibility Age 65+, Disability/NonMAGI (3)
Medicaid Eligibility and Enrollment Survey (7)
Medicaid Home Care/HCBS Survey (1)
Medicaid Watch (23)
Women's Health Survey (4)

Filter

Past Week
Past Month
Past 6 Months
Past Year
Custom
Start Date

End Date

Clear Selections

Event (147)
Fact Sheet (173)
FAQs (423)
Feature (279)
From Drew Altman (189)
Interactive (40)
Issue Brief (556)
News Release (381)
Other Post (8)
Perspective (194)
Policy Watch (49)
Poll Finding (219)
Quick Take (21)
Report (106)
State Health Facts Indicator (37)
Tracker (8)
Video (11)

Clear Selections

Abortion (43)
ACA Marketplaces (526)
Access to Care (236)
Accountable Care Organizations (ACOs) (5)
Actuarial Value (7)
Administrative Costs (5)
Adolescents (11)
Affordability (194)
Alabama (3)
Alaska (5)
Arizona (4)
Arkansas (10)
Benefits (43)
Black or African American (5)
Build Back Better (6)
California (33)
Cancer (4)
Care Coordination (1)
Children (50)
Children's Health Insurance Program (CHIP) (51)
Chronic Diseases (16)
Colorado (11)
Congressional Budget Office (CBO) (7)
Connecticut (11)
Consumer Assistance (50)
Contraception (17)
Cost Sharing (129)
County-Level Data (11)
Courts (97)
Coverage (608)
Deficit Reduction (47)
Delaware (3)
Delivery System (38)
Demographics (19)
Diabetes (5)
Disability (67)
Disproportionate Share Hospital (DSH) (4)
District of Columbia (7)
Dual Eligible Individuals (39)
Ebola (2)
Economy (28)
Eligibility (86)
Employer-Sponsored Health Insurance (156)
Employment (11)
En Español (25)
End of Life (4)
Enrollment (204)
Family Planning (53)
Federal Budget (83)
Financing (127)
Florida (7)
Food Security and Nutrition (3)
Food Stamps (2)
Fraud, Waste and Abuse (2)
Gender Identity (9)
Georgia (5)
Greater Than HIV (1)
Gun Violence (3)
Hawaii (2)
Health Care Markets (2)
Health Care Utilization (9)
Health Centers (18)
Health I.T. (17)
Health Status (18)
Health System Performance (4)
Health Workforce (17)
Heart Disease (1)
High-Deductible Plans (9)
High-Risk Pools (9)
Hispanic or Latino (4)
HIV/AIDS in U.S. (45)
Home care/HCBS (26)
Hospitals (32)
Idaho (2)
Illinois (5)
Income and Assets (4)
Indiana (10)
Individual Mandate (54)
Individual Market (307)
International Comparisons (4)
International Cooperation (1)
Iowa (4)
Kansas (2)
Kentucky (15)
Long-Term Care (43)
Louisiana (7)
Low Income (119)
Maine (7)
Managed Care (38)
Maryland (11)
Massachusetts (13)
Maternal and Child Health (12)
Measles (2)
Medicaid Work Requirements (16)
Medical Loss Ratio (MLR) (17)
Medical Technology (4)
Medicare Advantage (27)
Medicare Part D (29)
Medicare's Future (31)
Medicare-for-all (60)
Medigap (1)
Michigan (12)
Minnesota (2)
Mississippi (3)
Missouri (7)
Montana (4)
Nebraska (2)
Nevada (10)
New Hampshire (4)
New Jersey (2)
New Mexico (5)
New York (8)
North Carolina (5)
North Dakota (2)
Nurses (1)
Nursing Facilities (6)
Obesity (4)
Ohio (12)
Oklahoma (3)
Opioids (11)
Oral Health (7)
Oregon (9)
Over-the-Counter Contraceptives (5)
Paid Leave (1)
Pennsylvania (6)
Physicians (26)
Politics (423)
Pre-existing Conditions (99)
Pregnancy (8)
Premium Support (10)
Premiums (159)
Prescription Drugs (116)
Prevention (48)
Prices (23)
Prior Authorization (2)
Public Health (32)
Puerto Rico/Virgin Islands (7)
Quality Measures (13)
Quality of Life (1)
race (1)
Race/Ethnicity (28)
Rate Review (10)
Reproductive Health (96)
Retiree Coverage (4)
Rhode Island (6)
Rural Health (4)
Safety Net (42)
Seniors (67)
Sexual Orientation (1)
Sexually Transmitted Diseases (STDs) (1)
Small Group Coverage (27)
Smoking (1)
Social Media (4)
South Carolina (5)
South Dakota (2)
State Budgets (97)
State-Level Data (91)
Stigma (1)
Subsidies (171)
Substance Use (1)
Taxes (46)
Telehealth (1)
Tennessee (9)
Texas (11)
Treatment (1)
U.S. Government Programs (1)
U.S. Military (4)
Utah (10)
Vaccines (4)
Vermont (6)
Virginia (11)
Voting (2)
Waivers (80)
Washington (18)
Wellness Programs (12)
West Virginia (5)
Wisconsin (6)
Wyoming (2)
Zika Virus (12)

Clear Selections

Beyond the Data (18)
Employer Health Benefit Survey (6)
Health Policy 101 (2)
Health System Tracker (21)
Health Tracking Poll (327)
Health Wonk Shop (2)
KFF Health News Announcements (1)
KFF/NPR Surveys (8)
KFF/Washington Post Surveys (8)
Medicaid Budget Survey (1)
Medicaid Eligibility Age 65+, Disability/NonMAGI (3)
Medicaid Eligibility and Enrollment Survey (7)
Medicaid Home Care/HCBS Survey (1)
Medicaid Watch (23)
Women's Health Survey (4)

List Grid

2,711 - 2,720 of 2,762 Results

Insurer Strategies to Control Costs Associated with Weight Loss Drugs

Jun 12, 2024
Issue Brief

Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a an analysis of 2024 federal plan data.
The Uncertain Future of Policies to Promote Access and Affordability Put in Place During the COVID-19 Pandemic

May 19, 2022
Perspective

In this column for the JAMA Health Forum, Larry Levitt highlights four changes implemented during the COVID-19 pandemic that helped to make health care more accessible and affordable and the prospects for those changes to telehealth, COVID-19 coverage, Medicaid and marketplace premiums continuing beyond the pandemic’s end.
For ACA Enrollees, How Much Premiums Rise Next Year is Mostly up to Congress

May 18, 2022
Policy Watch

Most customers with coverage through Affordable Care Act's marketplaces will face big premium increases next year if Congress doesn’t extend the temporary enhanced tax credits included in the American Rescue Plan Act (ARPA) of 2021. If the outcome isn’t clear by summer, fall open enrollment could be a mess.
Private Insurers Expect to Pay $1 Billion in Rebates to Consumers This Year for Setting Premiums Too High Relative to Medical Costs

Jun 1, 2022
News Release

Private insurance companies are expecting to pay out $1 billion in rebates to consumers this fall under an Affordable Care Act provision that requires insurers to spend the bulk of customers’ premium payments on care, a new KFF analysis finds. Rebates are based on insurers’ experiences over the previous three years.
Use of ACA preventive services potentially affected by Braidwood v. Becerra

May 25, 2023
Issue Brief

This analysis finds that about 10 million privately insured people received at least one ACA preventive service or drug that could be affected by a now-stayed U.S. District Court ruling, which found the Affordable Care Act's (ACA) requirement to cover certain preventive services without any cost sharing to be partially unconstitutional.
KFF Health Tracking Poll May 2023: Health Care in the 2024 Election and in the Courts

May 26, 2023
Feature

Nearly a year after the Supreme Court overturned Roe v. Wade, this poll examines the public's views of abortion and the Supreme Court, and knowledge about mifepristone, a medication abortion drug that is the subject of another court case, the ACA's preventive services provision and HIV in the US.
About 1 in 20 People with Private Insurance Received Services that Could be Affected by a District Court Ruling Limiting the ACA’s Preventive Services Mandate

May 25, 2023
News Release

A new KFF analysis finds about 1 in 20 privately insured people (5.7%) received at least one ACA preventive service or drug that could be affected by a now-stayed U.S. District Court ruling in Braidwood Management v. Becerra, which found the Affordable Care Act’s (ACA) preventive services mandate partially unconstitutional.
One Year Since Dobbs: The Landscape of Abortion Policies Across the US

Jun 15, 2023
News Release

There has been intense focus on abortion policies across the United States since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization on June 24, 2022. That decision overturned Roe v. Wade, eliminating federal constitutional protections for abortion and putting the decision to restrict or protect abortion with the states.
What is the Centers for Medicare and Medicaid Services’ New AHEAD Model?

Jan 2, 2024
Issue Brief

In September 2023, the Centers for Medicare and Medicaid Services (CMS) announced a new opportunity for states to leverage federal funding on health care: the Advancing All-Payer Health Equity Approaches and Development (AHEAD) model. With this model, CMS – under the auspices of the CMS Innovation Center, also known as CMMI -- aims to reduce the rate of growth in health care spending, improve people's health, and reduce disparities in health outcomes. This issue brief answers some key questions about the new model and explores considerations for potential state and private participants.
What to Know About the FDA’s Recent Decision to Allow Florida to Import Prescription Drugs from Canada

Jan 12, 2024
Policy Watch

Florida’s plan to import certain prescription drugs from Canada represents the first time the Food and Drug Administration (FDA) has granted authority for a state to safely import prescription drugs from another country. This policy watch analysis unpacks some frequently asked questions related to state of Florida’s importation plan, including potential obstacles to implementation, who will benefit from any savings, and what types of drugs will (and will not) qualify for importation.